A股翻红，国产软件概念爆发，创新药强势反弹，多股涨停

Market Overview - On October 15, the market experienced fluctuations, with the Shanghai Composite Index rising by 0.1%, the Shenzhen Component Index remaining flat, and the ChiNext Index increasing by 0.22% at midday. The total trading volume exceeded 1.28 trillion yuan [1]. Sector Performance - The market showed a mixed performance with a focus on sectors such as pharmaceuticals, domestic software, and consumer goods. The domestic software sector rebounded due to positive stimuli, while the innovative drug sector also saw significant activity with multiple stocks hitting the daily limit [2][3]. Domestic Software Sector - The domestic software concept saw a strong upward trend on October 15, with stocks like Jiuxi Software and Geer Software both hitting the daily limit. Other stocks such as Pinming Technology and Haocen Software also experienced notable gains [4][5]. EDA Software Development - New Kai Lai's subsidiary, Wuhan Qiyunfang Technology Co., launched two domestically developed EDA (Electronic Design Automation) software products at the 2025 Bay Area Semiconductor Industry Expo. This development is seen as a milestone for China's semiconductor and electronic industrial software autonomy [7]. Innovative Drug Sector - The innovative drug sector rebounded strongly, with stocks like Guangshentang and Aonlikang hitting the daily limit. Other companies such as Lianhuan Pharmaceutical and Zhendong Pharmaceutical also saw significant increases [8][9]. Clinical Trials and Market Outlook - Heng Rui Pharmaceutical received approval for multiple injection drug clinical trials, indicating a recovery in the innovative drug sector. Analysts suggest that the recent market pullback presents a buying opportunity, with expectations of increased demand for innovative drug development [12].